Patricia S Steeg Selected Research

Patricia S Steeg Research Topics

Disease

62	Neoplasms (Cancer) 11/2021 - 11/2002
60	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2002
55	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2002
36	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2007
6	Triple Negative Breast Neoplasms 01/2019 - 10/2009
6	Neoplasm Micrometastasis 10/2015 - 08/2008
2	Fibrosis (Cirrhosis) 05/2018 - 01/2015
2	Osteosarcoma (Osteogenic Sarcoma) 08/2014 - 02/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2010 - 09/2007
1	Gliosis 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 05/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Inflammation (Inflammations) 11/2019
1	Neuroinflammatory Diseases 10/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2015

Drug/Important Bio-Agent (IBA)

18	Pharmaceutical PreparationsIBA 01/2019 - 09/2007
17	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2002
7	Small Interfering RNA (siRNA)IBA 01/2019 - 08/2007
6	DNA (Deoxyribonucleic Acid)IBA 12/2016 - 10/2009
6	Phosphotransferases (Kinase)IBA 02/2015 - 02/2003
5	Biological ProductsIBA 01/2021 - 02/2003
5	Lysophosphatidic Acid ReceptorsIBA 05/2018 - 08/2007
5	Biomarkers (Surrogate Marker)IBA 12/2016 - 07/2006
5	Paclitaxel (Taxol)FDA LinkGeneric 11/2013 - 04/2007
5	Messenger RNA (mRNA)IBA 12/2011 - 05/2007
4	Temozolomide (Temodar)FDA LinkGeneric 05/2020 - 02/2008
4	CytokinesIBA 11/2019 - 12/2008
4	ErbB Receptors (EGF Receptor)IBA 01/2019 - 05/2007
4	Histidine KinaseIBA 02/2018 - 08/2002
4	Trastuzumab (Herceptin)FDA Link 03/2015 - 10/2005
4	Lapatinib (GW572016)FDA Link 02/2015 - 08/2008
4	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 11/2014 - 09/2003
3	Histidine (L-Histidine)FDA Link 02/2018 - 08/2002
3	Hormones (Hormone)IBA 11/2014 - 05/2005
3	pazopanib FDA Link 06/2013 - 01/2011
2	AntibodiesIBA 01/2021 - 11/2020
2	Immunoconjugates (Immunoconjugate)IBA 11/2020 - 01/2019
2	human ERBB2 proteinIBA 11/2020 - 03/2015
2	Estrogen ReceptorsIBA 01/2019 - 01/2007
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 09/2007
2	Dextrans (Dextran)FDA Link 01/2018 - 11/2016
2	Coloring Agents (Dyes)IBA 01/2018 - 11/2016
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018 - 01/2013
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2016 - 11/2013
2	Texas redIBA 12/2016 - 11/2016
2	Complementary DNA (cDNA)IBA 07/2014 - 08/2008
2	Tyrosine Kinase InhibitorsIBA 06/2013 - 01/2013
2	Tyrosine (L-Tyrosine)FDA Link 06/2013 - 02/2003
2	IronIBA 07/2011 - 01/2007
2	Radiation-Sensitizing AgentsIBA 05/2011 - 02/2008
2	Histone Deacetylase InhibitorsIBA 10/2010 - 06/2009
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2010 - 03/2006
2	Vorinostat FDA Link 10/2009 - 06/2009
2	KSR-1 protein kinaseIBA 08/2008 - 08/2002
2	SteroidsIBA 08/2008 - 09/2003
2	AgarIBA 05/2005 - 09/2003
2	Serine (L-Serine)FDA Link 02/2003 - 08/2002
1	Phenobarbital (Luminal)FDA Link 01/2021
1	Semaphorin-3AIBA 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 11/2020
1	prexasertibIBA 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2019
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019
1	Transferrin (beta 2 Transferrin)IBA 01/2019
1	tropomyosin kinaseIBA 01/2019
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2019
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2019
1	Death Domain ReceptorsIBA 01/2019
1	Dynamin IIIBA 01/2019
1	Dynamins (Dynamin)IBA 01/2019
1	GTP Phosphohydrolases (GTPases)IBA 01/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2019
1	CaspasesIBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Conditioned Culture MediaIBA 01/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2019
1	Nucleoside-Diphosphate KinaseIBA 02/2018
1	Succinic Acid (Succinate)IBA 02/2018
1	phosphohistidineIBA 02/2018
1	Phosphates (Orthophosphate)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Vinorelbine (Navelbine)FDA LinkGeneric 12/2016
1	MicroRNAs (MicroRNA)IBA 11/2015
1	salicylhydroxamic acid (SHAM)IBA 10/2015
1	Capecitabine (Xeloda)FDA Link 02/2015
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2015
1	IntegrinsIBA 01/2015
1	Mitogen-Activated Protein Kinase 14IBA 10/2014
1	tempolIBA 07/2014

Therapy/Procedure

30	Therapeutics 11/2021 - 02/2003
5	Drug Therapy (Chemotherapy) 01/2019 - 10/2009
5	Lasers (Laser) 03/2014 - 11/2002
4	Radiotherapy 01/2019 - 08/2008
2	Craniotomy 11/2016 - 06/2013
2	Injections 07/2014 - 11/2013
2	Chemoprevention 05/2011 - 12/2006
1	Secondary Prevention 05/2020
1	Combined Modality Therapy 01/2019
1	Immunotherapy 01/2019
1	Ligation 03/2015